NOW:  COVID TESTING for our patients being done in our office.  Call 317-621-9000 weekdays for an appointment.
3/31/21:  COVID-19 VACCINE for teens age 16 and older can be scheduled beginning 3/31/21 by visit https://vaccine.coronavirus.in.gov/ or calling 211.  Northpoint Pediatrics is not currently a vaccination site, however, our pediatricians are strong believers in the vaccine and recommend it for those eligible.  You can learn more about eligibility at https://www.coronavirus.in.gov/vaccine/.    
Get Medical Advice:  Helpful resources to help you know how to best care for your child.

Research Experience

2014

  • Healthy Term Infants Fed Milk Based Formulas with a Supplemental Carotenoid
  • Study of a Diagnostic Device for the Detection of Influenza A, Influenza B, and RSV
  • Vaccine clinical trial to assess the lot consistency, safety and tolerability and immunogenicity of a meningococcal vaccine in healthy subjects ages >10 to  <19 years of age   
  • Immunogenicity and safety study of combined measles-mumps-rubella vaccine in subjects four to six years of age. 
  • A Phase II, Randomized Controlled, Observer-Blinded Trial, to Access the Safety, Tolerability and Immunogenicity of Gardasil® (HPV) Vaccine and rLP2086 Vaccine When Administered Concomitantly in Health Subjects aged > 11 to < 18 Years of Age  
 
2013
  • Growth and Tolerance of Young Infants Fed Infant Formulas

2012

  • An Immunogenicity and Safety Evaluation of Menactra® (Meningococcal Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered to Healthy Subjects at 9 Months and Concomitantly with Pentacel® at 15 to 18 Months of Age
  • Immunogenicity and safety study of GSK Biologicals’ combined measles-mumps-rubella vaccine in subjects four to six years of age.
  • Tolerance and Compliance of Infants Fed and Extensively Hydrolyzed Infant Formula

2011

  • A Phase II, Randomized Controlled, Observer-Blinded Trial, to Access the Safety, Tolerability and Immunogenicity of Gardasil® (HPV) Vaccine and rLP2086 Vaccine When Administered Concomitantly in Health Subjects aged > 11 to < 18 Years of Age
  • A Safety and Immunogenicity Study of DTaP-IPV Compared to Daptacel + IPOL as the 5th Dose in Children 4-6 years of Age
  • Growth and Tolerance of Young Infants Fed Infant formula
  • Ex Vivo Exploratory Analysis in Healthy Full Term Infants
  • Nasal Swab Collection for the Detection of Influenza A&B
  • Throat Swab and Oral Fluid Collection for the Detection of Group A Streptococcus

2010

  • An Observational Study to Describe Pediatric Influenza Vaccine Coverage among Practicing Pediatricians in the United States
  • Growth and Tolerance of Healthy Term Infants to a New Infant Formula

2009

  • An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Among Premature Infants
  • A Study of the Tolerance of Healthy Term Infants Fed Infant Formulas